COVID-19

Moderna’s COVID Vaccine Shows Promise in Early Trial: Study

CHICAGO — U.S. biotech firm Moderna’s coronavirus vaccine has successfully triggered an immune response in all volunteers against COVID-19 during preliminary testing, according to a study in the New England Journal of Medicine.

SOURCES: The New England Journal of Medicine, Moderna, Stat News

TomoNews is your best source for real news. We cover the funniest, craziest, and most talked-about stories on the internet. If you’re laughing, we’re laughing. If you’re outraged, we’re outraged. We tell it like it is. And because we can animate stories, TomoNews brings you news like you’ve never seen before.

You Idiot! – People doing stupid things

Recent Uploads – The latest stories brought to you by TomoNews

Thanks for watching TomoNews!
Like TomoNews on Facebook ►►
Follow us on Twitter ►► @tomonewsus
Follow us on Instagram ►► @tomonewsus
Subscribe to TomoNews ►►
Watch more TomoNews ►►

Visit our website for all the latest videos:
Check out our Android app:
Check out our iOS app:

Get top stories delivered to your inbox every day: